Archives
Press Releases
advertisement
August 18, 2021
- FDA approves Lyumjev® (insulin lispro-aabc injection) 100 units/mL for use in insulin pumps
- Insulet Announces FDA Clearance of Lyumjev® Rapid-Acting Insulin for Use with Omnipod® Products in the United States
- Matthew Hornberger Named Chief Executive Officer at Association of Diabetes Care & Education Specialists
- CVS Replaces Lantus® With Basaglar® Biosimilar
July 14, 2021
June 30, 2021
- New T1D Exchange Data at American Diabetes Association 81st Scientific Sessions Highlight Patient Care Inequities
- ViaCyte Reports Compelling Preliminary Clinical Data from Islet Cell Replacement Therapy for Patients with Type 1 Diabetes
- Bigfoot Unity™ Program Now Available in US, Revolutionizes How Clinicians Support Patients to Successfully Manage their Diabetes
- Tandem Diabetes Care Announces Presentations Demonstrating Positive Real-World Improvements with Control-IQ Technology Across Diverse Populations
- Walmart Revolutionizes Insulin Access & Affordability for Patients With Diabetes With the Launch of the First and Only Private Brand Analog Insulin
advertisement